Introduced
S. 5571
Introduced in Senate · October 6, 2026September 28, 2026
Mrs. Blackburn (for herself, Mr. Schiff, Mr. Lankford, and Mr. Budd) introduced the following bill; which was read twice and referred to the Committee on Finance
A BILL
To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Biosimilars Access and Affordability Act”.